Skip to search formSkip to main contentSkip to account menu

NSC-102816

Known as: NSC 102816, NSC102816 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Azacitidine

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1982
1982
Phase II study of 5‐azacytidine in sarcomas of bone
Eight PATIENTS WITH OSTEOGENIC SARCOMA and seven patients with Ewing's sarcoma, all with advanced metastatic disease refractory… 
1978
1978
Antitumor activity of pyrazofurin (nsc 140395) in combination with 5-azacytidine (nsc 102816) in mice. Abstr.
1975
1975
Combination therapy with 5-azacytidine (NSC-102816) and methyl-GAG (NSC-32946) in previously treated adults with acute nonlymphocytic leukemia.
1975
1975
Combination therapy with 5-azacytidine (NSC-102816) and methyl-GAG (NSC-32946) in previously treated adults with acute nonlymphocytic leukemia.
1975
1975
The effects of drug combinations on the metabolism and excretion of 5- -azacytidine (5-azacr, nsc 102816) in bdf1 mice. Abstr.
1974
1974
Comparison of 5-azacytidine (NSC-102816) with CCNU (NSC-79037) in the treatment of patients with breast cancer and evaluation of the subsequent use of cyclophosphamide (NSC-26271).
1973
1973
Hepatotoxicity of 5-azacytidine (NSC-102816) (a clinical and pathologic study).
1972
1972
Kinetics of the reduction in viability of cultured L1210 leukemia cells exposed to 5-azacytidine (NSC-102816).